Altered Microbiome Signature in Cushing's Syndrome Persists Beyond Remission
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae887 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von German Rubinstein und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medizinische Klinik und Poliklinik IV, Innenstadt Klinikum der Universität München, 80336 Munich, Germany. Hauptthemen laut MEDLINE: Cushing Syndrome, Gastrointestinal Microbiome, Dysbiosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Hellenic Foundation for Research and Innovation, Clinical Research Priority.
Abstract (Originalsprache)
Context
Patients with Cushing's syndrome (CS) suffer from metabolic and cardiovascular comorbidities caused by hypercortisolism. The human gut microbiome responds to different pathological conditions.
Objective
The aim of our study was to analyze the effect of chronic endogenous cortisol excess on the gut microbiome.
Methods
We prospectively recruited 18 patients with endogenous CS of different etiologies (mainly pituitary CS, n = 13). Patients provided a stool sample during active CS and 1 to 2 years after successful surgical treatment being in biochemical remission. In addition, 36 patients, in whom CS was excluded, served as an obese control group and 108 samples from healthy lean students were used as a reference group. Amplicons of the V3/V4 region of the 16S ribosomal RNA gene, from every sample, were sequenced and clustered into operational taxonomic units. The microbial profiles of CS patients were then compared to the control and reference groups using R scripts.
Results
In comparison to lean references, the gut microbiome of patients with florid CS demonstrated a disturbed microbial profile. Microbial dysbiosis of patients with CS was maintained even after biochemical remission following curative surgery.
Conclusion
Patients with CS have a distinct and disturbed gut microbiome that persists even after surgery, indicating a possible target for additional probiotic interventions to accelerate convergence to a healthy microbiome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medizinische Klinik und Poliklinik IV, Innenstadt Klinikum der Universität München, 80336 Munich, Germany.
- Department of Clinical Microbiology, School of Medicine, University of Crete, 70013 Heraklion, Greece.
- Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, UniversitätsSpital Zürich (USZ) und Universität Zürich (UZH), 8091 Zurich, Switzerland.
- The LOOP Zurich-Medical Research Center, 8044 Zurich, Switzerland.
ORCID-Profile: German Rubinstein, Anna Riester, Felix Beuschlein, Martin Reincke, Katrin Ritzel
Förderung
- Deutsche Forschungsgemeinschaft
- Hellenic Foundation for Research and Innovation
- Clinical Research Priority
- University of Zurich
Zitieren
APA
Rubinstein, G., Lagkouvardos, I., Intze, E., Osswald, A., Zopp, S., Braun, L. T., Albani, A., Künzel, H., Riester, A., Beuschlein, F., Reincke, M., & Ritzel, K. (2025). Altered Microbiome Signature in Cushing's Syndrome Persists Beyond Remission. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae887
Vancouver
Rubinstein G, Lagkouvardos I, Intze E, Osswald A, Zopp S, Braun LT, et al. Altered Microbiome Signature in Cushing's Syndrome Persists Beyond Remission. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae887
BibTeX
@article{Rubinstein2025,
author = {Rubinstein, German and Lagkouvardos, Ilias and Intze, Evangelia and Osswald, Andrea and Zopp, Stephanie and Braun, Leah Theresa and Albani, Adriana and Künzel, Heike and Riester, Anna and Beuschlein, Felix and Reincke, Martin and Ritzel, Katrin},
title = {Altered Microbiome Signature in Cushing's Syndrome Persists Beyond Remission},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae887}
}
EUVIMED